| title | Vulnerability of Down's syndrome (DS) patients to severe COVID-19 | ||
|---|---|---|---|
| featured | false | ||
| weight | 100 | ||
| doi | https://doi.org/10.1016/j.eclinm.2021.100769 | ||
| projects |
|
||
| journal | EClinical Medicine | ||
| month | February | ||
| year | 2021 |
Providing data and support to the Trisomy 21 Society, a study was conducted to determine if health conditions, immune dysfunction, and premature aging associated with trisomy 21 (Down syndrome, DS) may impact the clinical course of COVID-19. Whilst signs/symptoms of COVID-19 and risk factors for severe disease course are similar to the general population, individuals with DS present significantly higher rates of medical complications and mortality, especially from age 40.